Laboratory Head - Molecular imaging/Radioligand Therapy (80-100%*)

318683BR
May 24, 2021
Switzerland

Job Description

Applications are invited for a Laboratory Head position in Oncology Research that will carry out cutting-edge research in the areas of molecular imaging and radioisotope-based therapies together with leading basic research groups within NIBR. The candidate will be responsible for small animal molecular imaging (PET/SPECT/uCT) and drug discovery pharmacology activities within the Radioligand Therapy portfolio.

We seek an experienced, motivated and ambitious scientist wishing to continue a successful scientific career in a fast-paced drug discovery environment. The position is based at the Novartis Institutes of BioMedical Research (www.nibr.com) in Basel, Switzerland.

The ideal candidate should have a strong background in the molecular imaging modalities: PET, SPECT and uCT and a solid expertise and knowledge in developing Radioligand Therapies with a proven ability to conduct multidisciplinary research in a competitive field and an excellent record of achievements. The successful candidate will have solid expertise with rodent in vivo models and is expected to play a key role in the establishment of novel rodent models for Radioligand Therapies in the field of cancer.

Required skills and accountabilities:
• Lead a laboratory with expertise in nuclear medicine and innovative imaging modalities including PET/SPECT/uCT
• Perform biodistribution studies and metabolites analysis ex vivo
• Engage in independent research that will lead to innovative findings and novel fundamental insights
• Lead and manage cross-functional projects and external collaborations. Drive the project decision-making process, conceptualize and drive research projects to completion

Minimum Requirements

NIBR
Oncology NIBR
Switzerland
Basel
Research & Development
Full Time
Regular
No
318683BR

Laboratory Head - Molecular imaging/Radioligand Therapy (80-100%*)

Apply to Job Access Job Account